CA2602853A1 - Ring closing and related methods and intermediates - Google Patents

Ring closing and related methods and intermediates Download PDF

Info

Publication number
CA2602853A1
CA2602853A1 CA002602853A CA2602853A CA2602853A1 CA 2602853 A1 CA2602853 A1 CA 2602853A1 CA 002602853 A CA002602853 A CA 002602853A CA 2602853 A CA2602853 A CA 2602853A CA 2602853 A1 CA2602853 A1 CA 2602853A1
Authority
CA
Canada
Prior art keywords
group
formula
compound
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002602853A
Other languages
English (en)
French (fr)
Inventor
David S. Hays
Sonja S. Mackey
William H. Moser
Doris Stoermer
Matthew R. Radmer
Shri Niwas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2602853A1 publication Critical patent/CA2602853A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA002602853A 2005-04-01 2006-03-31 Ring closing and related methods and intermediates Abandoned CA2602853A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66784005P 2005-04-01 2005-04-01
US60/667,840 2005-04-01
PCT/US2006/012022 WO2006121528A2 (en) 2005-04-01 2006-03-31 Ring closing and related methods and intermediates

Publications (1)

Publication Number Publication Date
CA2602853A1 true CA2602853A1 (en) 2006-11-16

Family

ID=37397032

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002602853A Abandoned CA2602853A1 (en) 2005-04-01 2006-03-31 Ring closing and related methods and intermediates

Country Status (6)

Country Link
US (1) US8168802B2 (enExample)
EP (1) EP1863770A4 (enExample)
JP (1) JP2008535831A (enExample)
AU (1) AU2006244635A1 (enExample)
CA (1) CA2602853A1 (enExample)
WO (1) WO2006121528A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Cd5+b細胞リンパ腫の治療方法
AU2004315876B2 (en) 2003-10-03 2011-05-26 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
EP1682544A4 (en) 2003-11-14 2009-05-06 3M Innovative Properties Co HYDROXYLAMINE SUBSTITUTED IMIDAZO RING COMPOUNDS
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006028962A2 (en) 2004-09-02 2006-03-16 3M Innovative Properties Company 1-alkoxy 1h-imidazo ring systems and methods
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
CA2597324C (en) 2005-02-09 2015-06-30 Coley Pharmaceutical Group, Inc. Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
WO2006091647A2 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1948173B1 (en) * 2005-11-04 2013-07-17 3M Innovative Properties Company Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
US8951528B2 (en) 2006-02-22 2015-02-10 3M Innovative Properties Company Immune response modifier conjugates
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
RS55819B1 (sr) 2010-08-17 2017-08-31 3M Innovative Properties Co Kompozicije sa lipidiranim modifikatorom imuno-odgovora, formulacije, i postupci
MX347240B (es) 2011-06-03 2017-04-20 3M Innovative Properties Co Ligadores heterobifuncionales con segmentos polietilenglicol y conjugados modificadores de la respuesta inmunitaria elaborados a partir de los mismos.
MX355623B (es) 2011-06-03 2018-04-25 3M Innovative Properties Co Hidrazino-1h-imidazoquinolin-4-aminas y conjugados elaborados a partir de las mismas.
JP5935123B2 (ja) * 2011-08-22 2016-06-15 国立研究開発法人産業技術総合研究所 高温高圧クロスカップリング法
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
WO2017040233A1 (en) 2015-08-31 2017-03-09 3M Innovative Properties Company GUANIDINE SUBSTITUTED IMIDAZO[4,5-c] RING COMPOUNDS
CN107922416B (zh) * 2015-08-31 2021-07-02 3M创新有限公司 含有取代的胍基团的咪唑并[4,5-c]环化合物
RU2722149C1 (ru) * 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
WO2018160552A1 (en) 2017-03-01 2018-09-07 3M Innovative Properties Company IMIDAZO[4,5-c] RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS
JP7197244B2 (ja) 2017-12-20 2022-12-27 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤として使用するための分岐鎖連結基を有するアミド置換イミダゾ[4,5-c]キノリン化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645976A1 (de) * 1966-06-18 1971-01-21 Ajinomoto Kk Verfahren zur Herstellung von Adenosin und 2',3'-O-Isopropylidenadenosin
US4420617A (en) * 1980-03-28 1983-12-13 Sterling Drug Inc. 5(Pyridinyl)pyridin-2-amines
DE3723070A1 (de) * 1987-07-11 1989-01-19 Bayer Ag Verfahren zur herstellung von substituierten pyridylalkylketonen
CA2131680C (en) 1993-09-17 2006-11-07 Gerhard Stucky Process for preparing imidazopyridine derivatives
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
AU2220801A (en) 1999-12-22 2001-07-03 Kyorin Pharmaceutical Co. Ltd. Tricyclic compounds and addition salts thereof
KR20020073211A (ko) 2000-02-09 2002-09-19 호쿠리쿠 세이야쿠 가부시키가이샤 1 에이치-이미다조피리딘유도체
US6677349B1 (en) * 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof

Also Published As

Publication number Publication date
WO2006121528A3 (en) 2007-09-13
EP1863770A4 (en) 2010-05-05
AU2006244635A1 (en) 2006-11-16
JP2008535831A (ja) 2008-09-04
US20110269965A1 (en) 2011-11-03
EP1863770A2 (en) 2007-12-12
WO2006121528A2 (en) 2006-11-16
US8168802B2 (en) 2012-05-01

Similar Documents

Publication Publication Date Title
US8168802B2 (en) Ring closing and related methods and intermediates
US20090306388A1 (en) Method for substituted ih-imidazo[4,5-c] pyridines
JP5247458B2 (ja) ヒドロキシ及びアルコキシ置換1h−イミダゾキノリン及び方法
US7943636B2 (en) 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2623541A1 (en) Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
WO2006026760A2 (en) 1-amino imidazo-containing compounds and methods
EP1869043A2 (en) Pyrazolopyridine-1,4-diamines and analogs thereof
US20070099901A1 (en) Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006028451A1 (en) 1-amino 1-h-imidazoquinolines
WO2007079086A1 (en) Pyrazoloalkyl substituted imidazo ring compounds and methods
WO2007143526A2 (en) Substituted tetrahydroimidazonaphthyridines and methods
WO2007106852A2 (en) Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
KR20120066062A (ko) 피라졸로피리딘 및 그의 유사체
WO2006086634A2 (en) Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
WO2008155745A2 (en) New process for the manufacture of 1h-imidazo[4,5-c]-quinoline ring systems
KAKEHI et al. Preparation of New Nitrogen-Bridged Heterocycles. XXIV.: Syntheses and Reactions of Pyrazolo [1, 5-a] pyridine-2-thiols.(2)
KR20150082308A (ko) 이미다조피리딘 유도체
AU2017324297B2 (en) Process for preparation of 2-(6-nitropyridin-3-yl)-9H-dipyrido[2,3-b;3',4'-d]pyrrole
筧昭一 et al. Preparation of new nitrogen-bridged heterocycles. XXIV. Syntheses and reactions of pyrazolo (1, 5-a) pyridine-2-thiols.(2).
MXPA01005374A (en) Sulfonamide compounds and uses thereof as medicines

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20131227